Back
Meritage Homes Vs. Sarepta Therapeutics Industry Stock Comparison
Buy
63
MTH
Meritage Homes
Last Price:
203.53
Seasonality Move:
7.37%
Sell
36
SRPT
Sarepta Therapeutics
Last Price:
124.65
Seasonality Move:
-1.39%
Buy
63
Meritage Homes (MTH)
is a Buy
Is Meritage Homes a Buy, Sell or Hold?
- The current Meritage Homes [MTH] share price is $203.74. The Score for MTH is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
- MTH is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
36
Sarepta Therapeutics (SRPT)
is a Sell
Is Sarepta Therapeutics a Buy, Sell or Hold?
- The current Sarepta Therapeutics [SRPT] share price is $124.53. The Score for SRPT is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
- SRPT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
MTH Stock Price Chart
What is Meritage Homes's stock price today?
-
The Meritage Homes share price today is $203.74
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MTH is experiencing slight selling pressure.
SRPT Stock Price Chart
What is Sarepta Therapeutics's stock price today?
-
The Sarepta Therapeutics share price today is $124.53
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing slight selling pressure.
MTH Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 3.7 | Buy |
Relative Strength Index (14 RSI): | 56.43 | Buy |
Chaikin Money Flow: | -45668 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (192.49 - 205.31) | Buy |
Bollinger Bands (100): | (167.91 - 197.45) | Buy |
SRPT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -3.18 | Sell |
Relative Strength Index (14 RSI): | 35.54 | Sell |
Chaikin Money Flow: | -49995 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (124.27 - 135.95) | Sell |
Bollinger Bands (100): | (123.89 - 147.49) | Sell |
MTH Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 204.47 | Sell |
20-day SMA: | 198.55 | Buy |
50-day SMA: | 193.73 | Buy |
200-day SMA: | 172.92 | Buy |
8-day EMA: | 202.79 | Buy |
20-day EMA: | 199.76 | Buy |
50-day EMA: | 192.74 | Buy |
200-day EMA: | 172.1 | Buy |
SRPT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 125.45 | Sell |
20-day SMA: | 127.75 | Sell |
50-day SMA: | 135.2 | Sell |
200-day SMA: | 127.53 | Sell |
8-day EMA: | 125.39 | Sell |
20-day EMA: | 128.04 | Sell |
50-day EMA: | 132.59 | Sell |
200-day EMA: | 128.64 | Sell |
Meritage Homes Earnings Growth & MTH Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.11 per share, an increase next quarter of $0.88 per share, an increase this year of $1.31 per share, and an increase next year of $0.72 per share.
Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.96 per share, an increase next quarter of $2.81 per share, an increase this year of $4.41 per share, and an increase next year of $9.14 per share.
Meritage Homes Technical Analysis
Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Sarepta Therapeutics Technical Analysis
Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |